|Articles|February 1, 2004

Dashed: Hopes for an autism cure

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related to this article

Ecopipam data at MDS 2026 show early and sustained tic reduction in pediatric Tourette syndrome | Image Credit: © Puwasit Inyavileart - stock.adobe.com.

October 2nd, 2026

Ecopipam data at MDS 2026 show early and sustained tic reduction in pediatric Tourette syndrome

New ecopipam analyses show tic reduction within 8 weeks and sustained to 18 months in Tourette syndrome as the FDA weighs approval.

Trending on Contemporary Pediatrics

Brief evening screen time did not suppress melatonin in toddlers

Transitioning medically complex children to adult care

4 societies tie girls' and women's heart health to female life stages

25-valent pneumococcal vaccine hits all serotypes in infant trial

Self-harm risk peaks before ADHD medication initiation, study finds